Evidence map›Paper›PMID 30010947›Full record

ArticleGenome biology and evolution2018

Unexpected Genomic and Phenotypic Diversity of Mycobacterium africanum Lineage 5 Affects Drug Resistance, Protein Secretion, and Immunogenicity.

Louis S Ates, Anzaan Dippenaar, Fadel Sayes, Alexandre Pawlik, Christiane Bouchier, Laurence Ma, Robin M Warren, Wladimir Sougakoff, Laleh Majlessi, Jeroen W J van Heijst and 2 more

Open access · goldAbstract read
In one paragraph

Article in Genome biology and evolution, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Widespread loss-of-function mutations implicating preexisting resistance to new or repurposed anti-tuberculosis drugs.Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy · 2024
    Article
  5. Macrophage susceptibility to infection by GhanaianFrontiers in cellular and infection microbiology · 2023
    Article
  6. Review
  7. Gene evolutionary trajectories inProceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  8. Article
  9. Understanding the Genetic Diversity ofFrontiers in genetics · 2022
    Article
  10. Review
  11. Review
  12. Microbial genomics · 2021
    Article
  13. Article
  14. Article
  15. Phylogenomics ofMicrobial genomics · 2021
    Article
  16. Pathogenomic analyses ofMicrobial genomics · 2021
    Article
  17. PPE38-Secretion-Dependent Proteins ofFrontiers in immunology · 2021
    Article
  18. Article
  19. PE_PGRS proteins ofVirulence · 2020
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

Louis S AtesDepartment of Genomes and Genetics, Institut Pasteur, Unit for Integrated Mycobacterial Pathogenomics, CNRS UMR3525, Paris, France.
Anzaan DippenaarDST-NRF Centre of Excellence for Biomedical Tuberculosis Research; South African Medical Research Council Centre for Tuberculosis Research; Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Fadel SayesDepartment of Genomes and Genetics, Institut Pasteur, Unit for Integrated Mycobacterial Pathogenomics, CNRS UMR3525, Paris, France.
Alexandre PawlikDepartment of Genomes and Genetics, Institut Pasteur, Unit for Integrated Mycobacterial Pathogenomics, CNRS UMR3525, Paris, France.
Christiane BouchierDepartment of Genomes and Genetics, Institut Pasteur, Genomics Platform, Paris, France.
Laurence MaDepartment of Genomes and Genetics, Institut Pasteur, Genomics Platform, Paris, France.
Robin M WarrenDST-NRF Centre of Excellence for Biomedical Tuberculosis Research; South African Medical Research Council Centre for Tuberculosis Research; Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Wladimir SougakoffSorbonne Universités, INSERM, Centre d'Immunologie et des Maladies Infectieuses, CIMI-Paris, Team 13 (Bacteriology), Paris, France.
Laleh MajlessiDepartment of Genomes and Genetics, Institut Pasteur, Unit for Integrated Mycobacterial Pathogenomics, CNRS UMR3525, Paris, France.
Jeroen W J van HeijstDepartment of Experimental Immunology, Amsterdam UMC, University of Amsterdam, Amsterdam Infection & Immunity Institute, Amsterdam, The Netherlands.
Florence BrossierDepartment of Genomes and Genetics, Institut Pasteur, Unit for Integrated Mycobacterial Pathogenomics, CNRS UMR3525, Paris, France.
Roland BroschDepartment of Genomes and Genetics, Institut Pasteur, Unit for Integrated Mycobacterial Pathogenomics, CNRS UMR3525, Paris, France.
Centre National de la Recherche Scientifique · FRInstitut Pasteur · FRSouth African Medical Research Council · ZAAmsterdam University Medical Centers · NLInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mycobacterium africanum consists of Lineages L5 and L6 of the Mycobacterium tuberculosis complex (MTBC) and causes human tuberculosis in specific regions of Western Africa, but is generally not transmitted in other parts of the world. Since M. africanum is evolutionarily closely placed between the globally dispersed Mycobacterium tuberculosis and animal-adapted MTBC-members, these lineages provide valuable insight into M. tuberculosis evolution. Here, we have collected 15 M. africanum L5 strains isolated in France over 4 decades. Illumina sequencing and phylogenomic analysis revealed a previously underappreciated diversity within L5, which consists of distinct sublineages. L5 strains caused relatively high levels of extrapulmonary tuberculosis and included multi- and extensively drug-resistant isolates, especially in the newly defined sublineage L5.2. The specific L5 sublineages also exhibit distinct phenotypic characteristics related to in vitro growth, protein secretion and in vivo immunogenicity. In particular, we identified a PE_PGRS and PPE-MPTR secretion defect specific for sublineage L5.2, which was independent of PPE38. Furthermore, L5 isolates were able to efficiently secrete and induce immune responses against ESX-1 substrates contrary to previous predictions. These phenotypes of Type VII protein secretion and immunogenicity provide valuable information to better link genome sequences to phenotypic traits and thereby understand the evolution of the MTBC.

Indexed as

GenomicsPhylogenyAdultAnimalsBacterial ProteinsBase PairingComputational BiologyDrug Resistance, BacterialFemaleGenetic MarkersGenotypeHumansIsoniazidMaleMice, Inbred C57BLMiddle AgedBacterial ProteinsGenetic MarkersIsoniazid

Identifiers

PMID30010947
PMCPMC6071665
OpenAlexW2883858324

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.